Aarkstore - The Chinese Pharmaceuticals Market to 2024 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - The Chinese Pharmaceuticals Market to 2024 PowerPoint presentation | free to download - id: 6f779c-NDc1N



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - The Chinese Pharmaceuticals Market to 2024

Description:

The OTC drugs market in China was characterised by a late start, but fast growth, along with huge potential in comparison to that of the mature OTC markets in many western countries. For More Details : – PowerPoint PPT presentation

Number of Views:7

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - The Chinese Pharmaceuticals Market to 2024


1
Aarkstore - The Chinese Pharmaceuticals Market
to 2024
Category Healthcare
2
Aarkstore - The Chinese Pharmaceuticals Market to
2024
3
Summary
  •   The OTC drugs market in China was characterised
    by a late start, but fast growth, along with huge
    potential in comparison to that of the mature OTC
    markets in many western countries. Your company
    should be benefiting from this market access
    and this is only the OTC market what has the
    growth been throughout the whole Chinese pharma
    sector? This report will tell you.Chinas
    pharmaceutical sales growth is based on economic
    growth in the country This has resulted in
    increased healthcare expenditure internally, and
    increased manufacture and export. Increasing
    urbanisation, disposable income, aging
    population, health education, lifestyle diseases
    and government investments and initiatives for
    healthcare infrastructure improvement have helped
    the market growth considerably. Have you captured
    enough of the Chinese market?

4
Annually, an average of 190 is spent for the
treatment of diabetes, per patient, in China. By
2030, in China, diabetes is expected to cost Yuan
173.4bn (28 bn) a year. China is expected to top
the worlds diabetes tables both in terms of
sheer numbers and population prevalence. This is
true across a range of complaints and products
types your company must capture a segment of
this market TODAY.Anti-Counterfeiting and
anti-corruption How the Chinese market is
changingCounterfeit drugs are successfully
introduced in to the lengthy and complicated
delivery chain because of the highly fragmented
nature of the market. A lack of regular
inspections by any recognised drug enforcement /
regulatory bodies, again due to the highly
fragmented nature of production, allows
counterfeit / poor quality drugs into the Chinese
pharma market. Moreover, wide spread corruption
also helps the distribution of counterfeit drugs.
What are the Chinese regulators, and the global
manufacturers doing to change this? Find out in
this unique report.  
5
Table of Contents
  • Executive Summary  1.1. Chinese Pharmaceutical
    Market Review  1.2. Chapter Breakdown  1.3.
    Research and Analysis Methods  2. Drivers
    Restraints of the Chinese Pharmaceutical
    Market  2.1 An Ageing Population will drive
    pharmaceutical market growth in China  2.2
    Increase in Chinese urbanisation  2.3 Increase
    in Healthcare expenditure will increase drug
    demand in China  2.4 Government policies and
    changing environment for MNCs in China  2.5
    Increased demand for improved drug quality 

6
List Of Tables
  • Table 2.1.1 Percentage of Chinese population
    aged 60 and over / 65 and over in 2000, 2011
    2016  Table 2.1.2 Health spending in China,
    India and the US, 2009 2011 (/p/a percentage
    change)  Table 2.1.3 Total Health Expenditure
    (as of GDP) Selected Countries 2004 to
    2011  Table 2.1.4 Life expectancy Selected
    Countries 2004 to 2011  Table 2.2.1 Medical
    Coverage for Rural / Urban inhabitants in China
    2006 / 2009 (million people)  Table 2.2.2
    Major cities in China by population
    (2011)  Table 2.3.1 Chinas Health Care
    Expenditure Per Capita 2003-2011  Table 2.6.1
    Key New Drugs on the 2012 Essential Drugs List

7
List Of Figures
  • Figure 2.1.1 China population growth
    trend 1950-2013Figure 2.1.2 Projected
    comparison of Chinas population vs. other
    heavily populated countries 2016 (million
    people)Figure 2.1.3 Chinas Age distribution
    2001 to 2011Figure 2.1.4 Life expectancy in
    ChinaFigure 2.2.1 Chinas Rural and Urban
    population from 1990 to 2025 Billion
    PeopleFigure 2.2.2 Chinas Urbanisation Rate
    1990-2025 ()Figure 2.2.3 Per Capita
    Disposable Income Figure 2.3.1 China GDP
    growth trend (2004 2012)Figure 2.3.2 Chinas
    total health expenditure (as of GDP) 2004 to
    2011Figure 2.3.3 China healthcare expenditure
    per capita growth trend (2003 2011)
  •  

8
Related Reports
  • Generic Drugs Market in Japan 2015-2019
  • Lung Cancer-Global API Manufacturers, Marketed
    and Phase III Drugs Landscape, 2015
  • Metastatic Brain Tumor-Global API Manufacturers,
    Marketed and Phase III Drugs Landscape, 2015
  • Lupus Erythematosus-Global API Manufacturers,
    Marketed and Phase III Drugs Landscape, 2015
  • Metastatic Breast Cancer-Global API
    Manufacturers, Marketed and Phase III Drugs
    Landscape, 2015

9
Related Reports
  • Malaria-Global API Manufacturers, Marketed and
    Phase III Drugs Landscape, 2015
  • Metastatic Colorectal Cancer-Global API
    Manufacturers, Marketed and Phase III Drugs
    Landscape, 2015
  • Melanoma-Global API Manufacturers, Marketed and
    Phase III Drugs Landscape, 2015
  • Metastatic Hormone Refractory (Castration
    Resistant, Androgen-Independent) Prostate
    Cancer-Global API Manufacturers, Marketed and
    Phase III Drugs Landscape, 2015
  • Pharmaceuticals Healthcare Market Research
    Reports

10
The Chinese Pharmaceuticals Market to
2024 Published Sep 2014 160 Pages Chinas
pharmaceutical sales growth is based on economic
growth in the country This has resulted in
increased healthcare expenditure internally, and
increased manufacture and export.
Format Price
PDF 1799
Site License 3599
Enterprise Wide Licence 8499
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • Telefax No 91 22 4127 6660
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit
  • http//www.aarkstore.com
  • OR Mail us at
  • contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com